
A federal appeals court has sided with Medtronic Plc (NYSE:MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent related to the implantation of artificial heart valves.
At the heart of the case was Colibri's U.S. Patent No. 8,900,294, which outlines a method allowing surgeons to partially deploy and then recapture an artificial heart valve during implantation if the initial positioning appears off.